Navigation Links
Avreo Previews Version 7 RIS/PACS at RSNA
Date:11/27/2011

CHARLESTON, S.C., Nov. 27, 2011 /PRNewswire/ -- As a leader in unified RIS/PACS, Avreo continues to reinvent radiology workflow with its Version 7 release for preview at RSNA.  Version 7 represents an extensive platform change to support key areas of growth including:

  • All new modern design with focus on workflow and usability within radiology and meaningful use.
  • Cross-platform support, including Windows®, Mac OS® X, Apple® iOS, and Android™, to facilitate communication and information exchange, while embracing healthcare professionals' preferred tools. 
  • Advanced business reporting and dashboard visualization to identify trends so your organization can respond with actionable changes.

John Ciccarelli, Avreo Vice President of Sales and Marketing states, "While everyone raced to provide iPad functionality for referring physicians, we took the next step to provide Cross Platform connectivity."  Jonah Still, Avreo Chief Technology Officer continued "These advancements are really important for our customers as they improve usability and direct focus to clinical information while establishing a modern, fresh appearance."

Healthcare organizations can preview these and other Version 7 innovations at RSNA 2011 in Avreo booth 5423, Hall A. 

About Avreo

Avreo, founded in 1997, is a leading provider of Radiology Workflow Solutions for outpatient facilities, multi-specialty organizations, community hospitals, radiology groups, and orthopedic practices.  Our family of innovative solutions combines services from RIS, PACS, Dictation, Transcription, and Automatic Report Distribution within a single application, single database solution to encompass all the features a busy practice or hospital needs to operate efficiently.  Avreo is a privately held company based in Charleston, SC.  Avreo offers solutions on an operational (fee/exam) or capital acquisition payment model.  For more information, visit www.avreo.com or call 1-800-844-9926.


'/>"/>
SOURCE Avreo
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology
2. Misonix Previews New OsteoSculpt® Ultrasonic Bone Scalpel
3. Alere Previews Findings from Key Research Study on Medication Adherence at Integrated Benefits Institute Conference
4. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery
7. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
8. Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System
9. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
10. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
11. VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 2017  SARES•REGIS Group leased the first of ... Conejo Spectrum Business Park in Thousand ... Inc. , a biopharmaceutical company developing meaningful therapies ... have been underserved by scientific innovation, with an ... autoimmune and infectious disease. Before commencement ...
(Date:4/18/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 6.35% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:4/18/2017)... Research and Markets has announced the addition of the ... Radiopharmaceuticals Market, Forecast to 2023" report to their offering. ... This report assesses ... growth in the number of unit shipments over the next ... design and manufacture molecular imaging equipment. Market ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... April 21, 2017 , ... Providing broad access to ... opposition, but there is a better way to address this problem. , That was ... Pharmacy, Public Policy and Economics at the University of Southern California, who served as ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Brady ... that its B-595 and B-7569 vinyl label materials received certification ... warning labels are tested to remain intact and legible, for use on chemical drums ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... been named Agency of Record (AOR) for Theravent, Inc. , the makers ... Theravent’s parent company, Foundation Consumer Healthcare, is now working to expand distribution in ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... ... products, announced an exciting new partnership with the highly regarded and well renowned ... Management’s highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize ...
(Date:4/21/2017)... Salt Lake City, UT (PRWEB) , ... April 21, 2017 , ... ... medical staffing solutions, recently partnered with Advanced Patient Care of Utah (APCUT) and has ... the way for the next chapter of growth for our agency and our ability ...
Breaking Medicine News(10 mins):